TRVI · Trevi Therapeutics
AI read · Good for TRVI
The AI's read
The cash gives Trevi time to keep testing its drug, and 2 cough trials are now underway. Conference presentations also featured positive data for chronic cough. Enrollment is still early, the FDA has not yet agreed to a meeting about another patient group, and this call reported no new trial results. The funding and progress support Trevi, but the drug still needs to prove it works.